Eric Reuland leads operations at RIS Rx, helping scale the execution engine behind manufacturer-facing patient affordability and gross-to-net revenue protection solutions. His background blends high-performance operations with a data-driven approach to improving program reliability and outcomes. He holds a BS in Mechanical Engineering from the Massachusetts Institute of Technology as well as an MBA from the Stanford Graduate School of Business.
Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.
RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.